Figure S8 from Novel Spirocyclic Dimer, SpiD3, Targets Chronic Lymphocytic Leukemia Survival Pathways with Potent Preclinical Effects
Alexandria P. Eiken,Audrey L. Smith,Sydney A. Skupa,Elizabeth Schmitz,Sandeep Rana,Sarbjit Singh,Siddhartha Kumar,Jayapal Reddy Mallareddy,Aguirre A de Cubas,Akshay Krishna,Achyuth Kalluchi,M. Jordan Rowley,Christopher R. D'Angelo,Matthew A. Lunning,R. Gregory Bociek,Julie M. Vose,Amarnath Natarajan,Dalia El-Gamal crossref（2024）
摘要
Figure S8 shows the studies with SpiD3_AP in CLL.
查看译文
AI 理解论文
溯源树
样例
